The values of CAP, ALT, E, HOMA-IR and other clinical indices gradually increased in the control, NAFL and NASH groups, and the indices in the NAFL and NASH groups were mostly higher than the normal values of liver function tests. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.